G. D'aiuto

发表

Radiofrequency ablation in patients with primary breast carcinoma

F. Izzo, R. Thomas, P. Delrio, 2001, Cancer.

Rationale for a study adding tamoxifen to HRT.

P. Boyle, G. D'aiuto, M. Pizzichetta, 2002, European journal of cancer.

Chemoprevention Trial of Contralateral Breast Cancer with Fenretinide. Rationale, Design, Methodology, Organization, Data Management, Statistics and Accrual

L. Mariani, G. D'aiuto, M. R. del Turco, 1997, Tumori.

Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial.

G. D'aiuto, G. Botti, G. de Feo, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer.

M. Rinaldo, G. D'aiuto, G. Botti, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial

G. D'aiuto, G. Botti, N. Normanno, 2006, British Journal of Cancer.

Identification of a new subset of cells exhibiting dendritic phenotypes in patients affected by breast proliferative disorders.

G. D'aiuto, J. Guardiola, M. D'Aiuto, 2000, Human immunology.

Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients.

A Ciarmiello, R. Thomas, G. D'aiuto, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study.

M. Cazzaniga, B. Bonanni, L. Bisanti, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.

P. Boyle, G. D'aiuto, M. Pizzichetta, 2003, Journal of the National Cancer Institute.

Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort.

G. Botti, G. D'aiuto, G. Botti, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience

M. Rinaldo, G. D'aiuto, C. Pacilio, 2005, BMC Cancer.

Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels.

G. D'aiuto, G. Botti, G. Esposito, 1993, Cancer research.

Inequalities in the healthcare system and breast cancer survival

G. D'aiuto, A. Crispo, M. Montella, 2004, International journal of cancer.

Difference in breast cancer stage, treatment, and survival.

G. D'aiuto, A. Crispo, M. Montella, 2003, Archives of internal medicine.

Influence of delay to diagnosis on prognostic indicators of screen‐detected breast carcinoma

G. D'aiuto, A. Crispo, M. Montella, 2002, Cancer.

Identification of Cripto-1 as a Novel Serologic Marker for Breast and Colon Cancer

G. D'aiuto, G. Botti, J. Russo, 2006, Clinical Cancer Research.

PCNA/Cyclin and P-Glycoprotein as Prognostic Factors in Locally Advanced Breast Cancer. An Immunohistochemical, Retrospective Study

G. D'aiuto, G. Botti, G. Chiappetta, 1993, Tumori.

Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast

G. D'aiuto, G. Botti, F. Nuzzo, 2002, Cancer.

Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience

A. Vecchione, G. D'aiuto, A. Giordano, 2010, Cancer biology & therapy.

Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer.

G. D'aiuto, G. Botti, M. Salvatore, 1999, Cancer research.

Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype

G. D'aiuto, G. Botti, G. Ciliberto, 2014, Diabetology & Metabolic Syndrome.

Malignant Melanoma of the Nipple: A Case Studied with Radiolabeled Monoclonal Antibody

G. D'aiuto, G. Botti, L. Mansi, 1991, Tumori.

Silicone lymphadenopathy: Presentation of a further case containing asteroid bodies on fine‐needle cytology sample

G. D'aiuto, F. Fulciniti, G. Botti, 2015, Diagnostic cytopathology.

Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial.

G. D'aiuto, G. Signoriello, C. Pacilio, 2008, Critical reviews in oncology/hematology.

FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders

Liliane A. T. Arnaldi, G. D'aiuto, G. Botti, 2007, BMC Cancer.

HMGA1 Protein Overexpression in Human Breast Carcinomas

G. D'aiuto, G. Botti, G. Chiappetta, 2004, Clinical Cancer Research.

HMGA 1 Protein Overexpression in Human Breast Carcinomas : Correlation with ErbB 2 Expression

G. D'aiuto, G. Botti, G. Chiappetta, 2004 .

Anthropometric, Metabolic and Molecular Determinants of Human Epidermal Growth Factor Receptor 2 Expression in Luminal B Breast Cancer

G. D'aiuto, A. Giordano, M. Mottolese, 2015, Journal of cellular physiology.

Identification of Immune Cell Components in Breast Tissues by a Multiparametric Flow Cytometry Approach

M. Rinaldo, G. D'aiuto, E. Nicolai, 2022, Cancers.

Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma.

G. D'aiuto, G. Botti, M. Salvatore, 2000, Cancer research.

Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.

B. Bonanni, P. Boyle, G. D'aiuto, 2007, Journal of the National Cancer Institute.

Intragenic amplification and formation of extrachromosomal small circular DNA molecules from the PIP gene on chromosome 7 in primary breast carcinomas

Marina Ciullo, Marie-Anne Debily, John Guardiola, 2002, International journal of cancer.

Long-Acting versus Short-Acting Cephalosporins for Preoperative Prophylaxis in Breast Surgery:A Randomized Double-Blin d Trial Involving 1,766 Patients

R. Thomas, M. Rinaldo, G. D'aiuto, 1999, Chemotherapy.

Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study

G. D'aiuto, F. Caponigro, A. Budillon, 1998, Breast Cancer Research and Treatment.

In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients

G. D'aiuto, G. Botti, A. Ciarmiello, 1997, European Journal of Nuclear Medicine.

Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients

G. D'aiuto, G. Botti, A. Ciarmiello, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Gail Model Risk Factors: Impact of Adding an Extended Family History for Breast Cancer

M. Rinaldo, G. D'aiuto, C. Bosetti, 2008, The breast journal.

Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies.

G. D'aiuto, G. Botti, M. Salvatore, 1994, Cancer research.

Preoperative weekly cisplatin, epirubicin, and paclitaxel (PET) improves prognosis in locally advanced breast cancer patients: an update of the Southern Italy Cooperative Oncology Group (SICOG) randomised trial 9908.

G. D'aiuto, L. Vizioli, M. Santangelo, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

A Novel Pathogenic BRCA1 Splicing Variant Produces Partial Intron Retention in the Mature Messenger RNA

G. D'aiuto, F. Baralle, V. D’Argenio, 2016, International journal of molecular sciences.

Urokinase Receptor Interacts with αvβ5 Vitronectin Receptor, Promoting Urokinase-dependent Cell Migration in Breast Cancer

G. D'aiuto, G. Botti, M. Salvatore, 1999 .

Cisplatin–epirubicin–paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study

G. D'aiuto, I. Capasso, M. Bonito, 2000, Breast Cancer Research and Treatment.

Cisplatin–epirubicin–paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group

G. D'aiuto, I. Capasso, M. Bonito, 1999, Breast Cancer Research and Treatment.

A Phase I–II Study on a Gemcitabine-Cyclophosphamide-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients

P. Vallone, G. D'aiuto, G. Botti, 2002, Oncology.

Gemcitabine/cyclophosphamide/5-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patients: a Southern Italy Cooperative Oncology Group phase I/II study.

R. Thomas, G. Botti, G. D'aiuto, 2001, Seminars in oncology.

Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer.

R. Thomas, G. D'aiuto, G. Botti, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancer.

M. Rinaldo, G. D'aiuto, A. Petrillo, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

In vitro receptor imaging for characterization of human solid tumors.

G. D'aiuto, G. Botti, G. Esposito, 1994, Nuclear medicine and biology.

Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis

B. Bonanni, G. D'aiuto, Alberto Costa, 2007, Breast Cancer Research and Treatment.

Effect of Tamoxifen on Venous Thromboembolic Events in a Breast Cancer Prevention Trial

B. Bonanni, P. Boyle, G. D'aiuto, 2005, Circulation.

Reasons why COVID-19 survivors should follow dietary World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations: from hyper-inflammation to cardiac dysfunctions.

G. Botti, G. D'aiuto, G. Nunnari, 2021, European review for medical and pharmacological sciences.

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

M. Sporn, L. Mariani, G. D'aiuto, 1999, Journal of the National Cancer Institute.

Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience

G. D'aiuto, G. Ciliberto, A. Giordano, 2013, Journal of experimental & clinical cancer research : CR.

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

P. Vallone, G. D'aiuto, G. Botti, 2007, Cancer Chemotherapy and Pharmacology.

Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study

P. Vallone, G. D'aiuto, G. Botti, 2003, Cancer Chemotherapy and Pharmacology.

Surgery of the chest wall for involvement by breast cancer.

G. D'aiuto, G. Rocco, Marcellino Cicalese, 2010, Thoracic surgery clinics.

Determinant factors for diagnostic delay in operable breast cancer patients

G. D'aiuto, G. Fabbrocini, A. Crispo, 2001, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial

M. Rinaldo, G. D'aiuto, G. Botti, 2011, BMC Cancer.

Changing patterns of breast cancer stage at diagnosis in southern italy: hospital data as indicators of progressive changes.

G. D'aiuto, G. Botti, G. Fabbrocini, 2000, Preventive medicine.

BMI and breast cancer prognosis benefit: mammography screening reveals differences between normal weight and overweight women.

M. Rinaldo, G. D'aiuto, G. Ciliberto, 2015, Breast.

Scintimammography with 99mTc-MDP: experience of the National Cancer Institute of Naples.

R. Thomas, G. D'aiuto, S. Lastoria, 1998, European journal of radiology.

A two-month cisplatin-epirubicin-paclitaxel (PET) weekly administration is highly effective in large operable breast cancer. Final analysis of a SICOG phase II study

R. Thomas, G. D'aiuto, M. Bonito, 2005 .

Multimodal treatment strategy for locally advanced breast cancer.

G. D'aiuto, M. Montella, A. de Matteis, 1998, Journal of chemotherapy.

Self-Efficacy for Coping with Cancer Enhances the Effect of Reiki Treatments During the Pre-Surgery Phase of Breast Cancer Patients.

G. D'aiuto, F. Lucidi, G. Botti, 2017, Anticancer research.

An Assessment of Delays in Obtaining Definitive Breast Cancer Treatment in Southern Italy

G. D'aiuto, G. Botti, G. Fabbrocini, 2001, Breast Cancer Research and Treatment.

Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study

R. Thomas, G. Botti, G. D'aiuto, 2006, British Journal of Cancer.

Locally Advanced Breast Cancer: Role of Chemotherapy in Improving Prognosis

G. D'aiuto, G. Comella, G. Frasci, 2008 .

Biweekly Docetaxel-Irinotecan Treatment with Filgrastim Support Is Highly Active in Antracycline-Paclitaxel-Refractory Breast Cancer Patients

P. Vallone, G. D'aiuto, G. Botti, 2005, Oncology.

Estrogen Receptor-Negative and HER-2/neu-Positive Locally Advanced Breast Carcinoma: Therapy with Paclitaxel and Granulocyte-Colony Stimulating Factor

R. Thomas, G. D'aiuto, G. Comella, 2008 .

Molecular profiles of screen detected vs. symptomatic breast cancer and their impact on survival: results from a clinical series

M. Rinaldo, G. D'aiuto, G. Botti, 2013, BMC Cancer.

Weekly docetaxel plus gemcitabine or vinorelbine in refractory advanced breast cancer patients: a parallel dose-finding study. Southern Italy Cooperative Oncology Group (SICOG).

R. Thomas, P. Vallone, G. Botti, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches.

G. D'aiuto, V. D’Argenio, V. Precone, 2015, Clinica chimica acta; international journal of clinical chemistry.

Hormonotherapy with goserelin depot after adjuvant chemotherapy in premenopausal women with early breast cancer: Is there any benefit?

G. D'aiuto, F. Nuzzo, E. Rossi, 1998 .

Immediate breast reconstruction with the transverse rectus abdominis musculocutaneous flap after skin-sparing mastectomy.

R. Thomas, G. D'aiuto, P. Cortino, 2001, International surgery.

Characterization of 2 novel and 2 recurring BRCA1 germline mutations in breast and/or ovarian carcinoma patients from the area of Naples.

M. D'urso, G. D'aiuto, G. Viglietto, 2002, International journal of oncology.

Breast cancer screening, body mass index and prognosis benefit

M. Rinaldo, G. D'aiuto, G. Ciliberto, 2014, Journal of medical screening.

Vinorelbine plus 3-weekly trastuzumab in metastatic breast cancer: a single-centre phase 2 trial

G. D'aiuto, G. Botti, G. Signoriello, 2007, BMC Cancer.

Association between mode of breast cancer detection and diagnosis delay.

C. la Vecchia, G. D'aiuto, G. Botti, 2009, Breast.

Combination of inositol and alpha lipoic acid in metabolic syndrome-affected women: a randomized placebo-controlled trial

G. D'aiuto, G. Botti, G. Ciliberto, 2013, Trials.

Metabolic syndrome, hyperinsulinaemia and body mass index as risk factors in breast cancer: National Cancer Institute of Naples experience

G. D'aiuto, G. Esposito, A. Crispo, 2009, Breast Cancer Research.

Tumour uptake of 57-cobalt-bleomycin in patients with breast cancer.

G. D'aiuto, G. Botti, M. Salvatore, 1993, European journal of cancer.

A 2-month cisplatin-epirubicin-paclitaxel (PET) weekly combination as primary systemic therapy for large operable breast cancer: a phase II study.

R. Thomas, G. Botti, G. D'aiuto, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Outcome Analysis of Breast Cancer Patients Receiving Breast-Conserving Surgery in Southern Italy

M. Rinaldo, G. D'aiuto, G. Botti, 2008, Journal of chemotherapy.

Is Gemcitabine plus Vinorelbine Active in Second-Line Chemotherapy of Metastatic Breast Cancer? A Single-Center Phase 2 Study

G. D'aiuto, C. Gridelli, M. Di Maio, 2003, Oncology.

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study.

M. Cazzaniga, B. Bonanni, L. Bisanti, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial.

G. D'aiuto, G. Botti, G. Esposito, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.